| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |